Mohammad S. Rostami

Array ( [id] => 1450878 [patent_doc_number] => 06455589 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-24 [patent_title] => 'Primary N-hydroxylamines' [patent_app_type] => B1 [patent_app_number] => 09/429412 [patent_app_country] => US [patent_app_date] => 1999-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18625 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/455/06455589.pdf [firstpage_image] =>[orig_patent_app_number] => 09429412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1494556 [patent_doc_number] => 06403347 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'HIV integrase inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/355692 [patent_app_country] => US [patent_app_date] => 1999-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7336 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403347.pdf [firstpage_image] =>[orig_patent_app_number] => 09355692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4315352 [patent_doc_number] => 06242496 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Pharmaceutical composition containing bupropion hydrochloride and a stabilizer' [patent_app_type] => 1 [patent_app_number] => 9/406906 [patent_app_country] => US [patent_app_date] => 1999-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2489 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242496.pdf [firstpage_image] =>[orig_patent_app_number] => 406906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1394128 [patent_doc_number] => 06545048 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-08 [patent_title] => 'Compositions and methods of treating cancer using compositions comprising an inhibitor or endothelin receptor activity' [patent_app_type] => B1 [patent_app_number] => 09/404626 [patent_app_country] => US [patent_app_date] => 1999-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 21 [patent_no_of_words] => 9842 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/545/06545048.pdf [firstpage_image] =>[orig_patent_app_number] => 09404626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1436047 [patent_doc_number] => 06355691 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'Urushiol therapy of transitional cell carcinoma of the bladder' [patent_app_type] => B1 [patent_app_number] => 09/399847 [patent_app_country] => US [patent_app_date] => 1999-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1125 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355691.pdf [firstpage_image] =>[orig_patent_app_number] => 09399847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1396962 [patent_doc_number] => 06541478 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-01 [patent_title] => 'Smoking cessation treatments using naltrexone and related compounds' [patent_app_type] => B1 [patent_app_number] => 09/397570 [patent_app_country] => US [patent_app_date] => 1999-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6269 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/541/06541478.pdf [firstpage_image] =>[orig_patent_app_number] => 09397570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1586468 [patent_doc_number] => 06359011 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Denaturants for sympathomimetic amine salts' [patent_app_type] => B1 [patent_app_number] => 09/391739 [patent_app_country] => US [patent_app_date] => 1999-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7672 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/359/06359011.pdf [firstpage_image] =>[orig_patent_app_number] => 09391739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4238323 [patent_doc_number] => 06143796 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Method for reducing development of free radical induced malignancies' [patent_app_type] => 1 [patent_app_number] => 9/389520 [patent_app_country] => US [patent_app_date] => 1999-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1783 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143796.pdf [firstpage_image] =>[orig_patent_app_number] => 389520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4350623 [patent_doc_number] => 06214856 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Indolecarboxamides, pharmaceutical compositions and methods of inhibiting calpain' [patent_app_type] => 1 [patent_app_number] => 9/380317 [patent_app_country] => US [patent_app_date] => 1999-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3034 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 216 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214856.pdf [firstpage_image] =>[orig_patent_app_number] => 380317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4305623 [patent_doc_number] => 06326390 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'Use of adenosine A3 receptor antagonists to inhibit tumor growth' [patent_app_type] => 1 [patent_app_number] => 9/377271 [patent_app_country] => US [patent_app_date] => 1999-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7566 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326390.pdf [firstpage_image] =>[orig_patent_app_number] => 377271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1550153 [patent_doc_number] => 06346543 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-12 [patent_title] => 'Use of a taxoid to treat abnormal cell proliferation in the brain' [patent_app_type] => B1 [patent_app_number] => 09/371838 [patent_app_country] => US [patent_app_date] => 1999-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7256 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/346/06346543.pdf [firstpage_image] =>[orig_patent_app_number] => 09371838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1596427 [patent_doc_number] => 06492389 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-10 [patent_title] => 'Small molecule inhibitors of BCL-2 proteins' [patent_app_type] => B1 [patent_app_number] => 09/357229 [patent_app_country] => US [patent_app_date] => 1999-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9134 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 354 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/492/06492389.pdf [firstpage_image] =>[orig_patent_app_number] => 09357229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1495664 [patent_doc_number] => 06403627 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Spin trapping pharmaceutical compositions and methods for use thereof' [patent_app_type] => B1 [patent_app_number] => 09/357297 [patent_app_country] => US [patent_app_date] => 1999-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7465 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403627.pdf [firstpage_image] =>[orig_patent_app_number] => 09357297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4269740 [patent_doc_number] => 06306897 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Calanolides for inhibiting BTK' [patent_app_type] => 1 [patent_app_number] => 9/354550 [patent_app_country] => US [patent_app_date] => 1999-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 11656 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 261 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306897.pdf [firstpage_image] =>[orig_patent_app_number] => 354550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4346744 [patent_doc_number] => 06284783 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Use of bisindolylmaleimide compounds to induce Fas-mediated apoptosis' [patent_app_type] => 1 [patent_app_number] => 9/328707 [patent_app_country] => US [patent_app_date] => 1999-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 22 [patent_no_of_words] => 11440 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284783.pdf [firstpage_image] =>[orig_patent_app_number] => 328707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4410077 [patent_doc_number] => 06310077 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Enterokinetic benzamide' [patent_app_type] => 1 [patent_app_number] => 9/325865 [patent_app_country] => US [patent_app_date] => 1999-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3714 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/310/06310077.pdf [firstpage_image] =>[orig_patent_app_number] => 325865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1550193 [patent_doc_number] => 06346552 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-12 [patent_title] => 'Breathing gas mixture containing perfluorocarbons' [patent_app_type] => B1 [patent_app_number] => 09/320310 [patent_app_country] => US [patent_app_date] => 1999-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1728 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/346/06346552.pdf [firstpage_image] =>[orig_patent_app_number] => 09320310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1435971 [patent_doc_number] => 06355614 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'Cyclic boroproline compounds' [patent_app_type] => B1 [patent_app_number] => 09/312565 [patent_app_country] => US [patent_app_date] => 1999-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 13357 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355614.pdf [firstpage_image] =>[orig_patent_app_number] => 09312565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1457739 [patent_doc_number] => 06391303 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Methods and compositions for inducing oral tolerance in mammals' [patent_app_type] => B1 [patent_app_number] => 09/101921 [patent_app_country] => US [patent_app_date] => 1999-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7882 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391303.pdf [firstpage_image] =>[orig_patent_app_number] => 09101921 [rel_patent_id] =>[rel_patent_doc_number] =>)